Metformin in non-diabetic hyperglycaemia: the GLINT feasibility RCT

Background: The treatment of people with diabetes with metformin can reduce cardiovascular disease (CVD) and may reduce the risk of cancer. However, it is unknown whether or not metformin can reduce the risk of these outcomes in people with elevated blood glucose levels below the threshold for diabe...

詳細記述

保存先:
書誌詳細
主要な著者: Simon J Griffin, M Angelyn Bethel, Rury R Holman, Kamlesh Khunti, Nicholas Wareham, Gwen Brierley, Melanie Davies, Andrew Dymond, Rose Eichenberger, Philip Evans, Alastair Gray, Colin Greaves, Kyla Harrington, Graham Hitman, Greg Irving, Sarah Lessels, Ann Millward, John R Petrie, Martin Rutter, Mike Sampson, Naveed Sattar, Stephen Sharp
フォーマット: Artigo
言語:Inglês
出版事項: NIHR Journals Library 2018-04-01
シリーズ:Health Technology Assessment
主題:
prevention
cardiovascular risk
cardiovascular disease
metformin
diabetes
type 2 diabetes
impaired glucose tolerance
hyperglycaemia
オンライン･アクセス:https://doi.org/10.3310/hta22180
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料